Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expressionWALLACE, Tiffany A; VONDERLINDEN, Dannielle; KAI HE et al.American journal of physiology. Cell physiology. 2004, Vol 56, Num 4, pp C981-C991, issn 0363-6143Article

Upregulation of thrombospondin-1 expression by leptin in vascular smooth muscle cells via JAK2- and MAPK-dependent pathwaysCHAVEZ, Ronaldo J; HANEY, Rebecca M; CUADRA, Rene H et al.American journal of physiology. Cell physiology. 2012, Vol 72, Num 1, issn 0363-6143, C179-C191Article

JAK2 V617F : implications for thrombosis in myeloproliferative diseasesHEXNER, Elizabeth O.Current opinion in hematology. 2007, Vol 14, Num 5, pp 450-454, issn 1065-6251, 5 p.Article

Janus kinase Inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?HARRISON, Claire; VERSTOVSEK, Srdan; MCMULLIN, Mary F et al.British journal of haematology. 2012, Vol 157, Num 4, pp 426-437, issn 0007-1048, 12 p.Article

Novel strategies for patients with chronic myeloproliferative disordersBAROSI, Giovanni; ROSTI, Vittorio.Current opinion in hematology. 2009, Vol 16, Num 2, pp 129-134, issn 1065-6251, 6 p.Article

Mutation acquise de la tyrosine kinase Jak2 et maladie de Vaquez = Acquired mutation of JAK2 tyrosine kinase and polycythaemia veraPARGADE, V; DARNIGE, L; GAUSSEM, P et al.Annales de biologie clinique (Paris). 2006, Vol 64, Num 1, pp 3-9, issn 0003-3898, 7 p.Article

Hypoxia upregulates Hsp90α expression via STAT5b in cancer cellsSE HYUNG PAK; YOUN HEE JOUNG; YE, Sang-Kyu et al.International journal of oncology. 2012, Vol 41, Num 1, pp 161-168, issn 1019-6439, 8 p.Article

2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2LEDEBOER, Mark W; PIERCE, Albert C; SHLYAKTER, Dina et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 23, pp 6529-6533, issn 0960-894X, 5 p.Article

Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell culturesYOU JIN WON; JONG YOON YOO; JONG HWAN LEE et al.Brain research. 2007, Vol 1154, pp 31-39, issn 0006-8993, 9 p.Article

Adipocyte-specific deficiency of Janus kinase (JAK) 2 in mice impairs lipolysis and increases body weight, and leads to insulin resistance with ageingSALLY YU SHI; LUK, Cynthia T; BRUNT, Jara J et al.Diabetologia (Berlin). 2014, Vol 57, Num 5, pp 1016-1026, issn 0012-186X, 11 p.Article

Analysis of JAK2 and STAT3 polymorphisms in patients with ankylosing spondylitis in Chinese Han populationCHAO CHEN; XUESONG ZHANG; YAN WANG et al.Clinical immunology (Orlando, Fla. Print). 2010, Vol 136, Num 3, pp 442-446, issn 1521-6616, 5 p.Article

Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutationBANG, Soo-Mee; LEE, Jong-Seok; MOON HEE LEE et al.Thrombosis and haemostasis. 2009, Vol 101, Num 3, pp 547-551, issn 0340-6245, 5 p.Article

Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatmentLAPECORELLA, Mario; TABILIO, Antonio; LUCCHESI, Alessandro et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 5, pp 453-457, issn 0957-5235, 5 p.Article

Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell linesLIU, R. Y; CHUN FAN; GARCIA, R et al.Blood. 1999, Vol 93, Num 7, pp 2369-2379, issn 0006-4971Article

Human malignant mesothelioma cell growth : Activation of janus kinase 2 and signal transducer and activator of transcription 1α for inhibition by interferon-γBUARD, A; VIVO, C; MONNET, I et al.Cancer research (Baltimore). 1998, Vol 58, Num 4, pp 840-847, issn 0008-5472Article

Where are we going with CML research?PERROTTI, D.Leukemia supplements (Print). 2012, Vol 1, Num 2, issn 2044-5210, S51-S53Conference Paper

6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of janus kinase 2-mediated jnk pathway in lipopolysaccharide-activated murine macrophagesUTO, Takuhiro; FUJII, Makoto; HOU, De-Xing et al.Biochemical pharmacology. 2005, Vol 70, Num 8, pp 1211-1221, issn 0006-2952, 11 p.Article

Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophagesOKUGAWA, Shu; OTA, Yasuo; KITAZAWA, Takatoshi et al.American journal of physiology. Cell physiology. 2003, Vol 54, Num 2, pp C399-C408, issn 0363-6143Article

Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cellsCRUZ, M. T; DUARTE, C. B; GONCALO, M et al.American journal of physiology. Cell physiology. 1999, Vol 46, Num 6, pp C1050-C1057, issn 0363-6143Article

Thrombocytémie essentielle. Apport de la mutation V617F de JAK2 pour la stratégie diagnostique, la physiopathologie et les modalités évolutives = Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcomeBRIERE, Jean.Bulletin de l'Académie nationale de médecine. 2007, Vol 191, Num 3, pp 535-548, issn 0001-4079, 14 p.Article